Healthcare entity
market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Amgen, the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 12.7 for the same window.
Last mentioned: Jun 28, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Amgen, the most common co-covered peer. They are less corroborated than the beat average, carrying 2 original sources each against 12.7 for the same window. At 5, the average consequence score sits below the same-window beat average of 6.6. Cencora appears in 1 tracked Healthcare story from June 28, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 21 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Cencora. Shared-story counts are live from our verified record — not editorial picks.
Amgen and NovoCure represent two extremes in healthcare delivery: a wholesale-dependent drug giant and a patient-centric device innovator. The comparison reveals how direct-to-patient models are reshaping oncology treatment accessibility and reimbursement dynamics.
Cencora is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
